THOMAS TAYLOR: Open Payments
NPI 1093040057 · FULTON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,023 in 68 payments from 14 companies in 2025. Trend: 2023 $814 · 2024 $1,042 · 2025 $1,023
Food & beverage: $1,023
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 12 | $178 |
| Otsuka America Pharmaceutical, Inc. | 8 | $162 |
| ABBVIE INC. | 17 | $158 |
| PFIZER INC. | 9 | $144 |
| Lilly USA, LLC | 6 | $100 |
| AstraZeneca Pharmaceuticals LP | 5 | $76 |
| Novo Nordisk Inc | 3 | $52 |
| Phathom Pharmaceuticals, Inc. | 2 | $35 |
| Ardelyx, Inc. | 1 | $28 |
| Lundbeck LLC | 1 | $26 |
Products named: REXULTI, VRAYLAR, MOUNJARO, NURTEC ODT, OTEZLA, EVENITY, AIRSUPRA, Rybelsus.
Industry payments across MS — which companies pay providers there.
